Podchaser Logo
Home
Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Released Wednesday, 23rd August 2023
Good episode? Give it some love!
Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Wednesday, 23rd August 2023
Good episode? Give it some love!
Rate Episode

Paul Wardle led switches at HRA Pharma and Pfizer and worked on iconic switch brands such as Viagra, Advil, Lipitor and Opill. In light of recent Rx-to-OTC switches, Paul, who is now founder at Beacon Associates, shares his perspectives from his decade-long switch experience. In this episode, Rusty and Paul discussed the underlying impacts switch products bring to consumer adherence and utilization, as well as the switch process and the new ACNU regulation.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features